Avalon GloboCare (ALBT) Competitors $3.81 -0.06 (-1.55%) As of 11:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALBT vs. JATT, TPST, CARA, CASI, TENX, CYTH, PTIX, KALA, PULM, and QNTMShould you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include JATT Acquisition (JATT), Tempest Therapeutics (TPST), Cara Therapeutics (CARA), CASI Pharmaceuticals (CASI), Tenax Therapeutics (TENX), Cyclo Therapeutics (CYTH), Protagenic Therapeutics (PTIX), KALA BIO (KALA), Pulmatrix (PULM), and Quantum Biopharma (QNTM). These companies are all part of the "pharmaceutical products" industry. Avalon GloboCare vs. JATT Acquisition Tempest Therapeutics Cara Therapeutics CASI Pharmaceuticals Tenax Therapeutics Cyclo Therapeutics Protagenic Therapeutics KALA BIO Pulmatrix Quantum Biopharma JATT Acquisition (NYSE:JATT) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk. Which has better valuation & earnings, JATT or ALBT? JATT Acquisition has higher earnings, but lower revenue than Avalon GloboCare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AAvalon GloboCare$1.33M4.72-$16.71M-$19.96-0.19 Does the MarketBeat Community favor JATT or ALBT? JATT Acquisition and Avalon GloboCare both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformJATT AcquisitionN/AN/AAvalon GloboCareN/AN/A Does the media favor JATT or ALBT? In the previous week, Avalon GloboCare had 1 more articles in the media than JATT Acquisition. MarketBeat recorded 1 mentions for Avalon GloboCare and 0 mentions for JATT Acquisition. Avalon GloboCare's average media sentiment score of 1.87 beat JATT Acquisition's score of 0.00 indicating that Avalon GloboCare is being referred to more favorably in the news media. Company Overall Sentiment JATT Acquisition Neutral Avalon GloboCare Very Positive Is JATT or ALBT more profitable? JATT Acquisition has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,125.59%. Avalon GloboCare's return on equity of 0.00% beat JATT Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% Avalon GloboCare -1,125.59%N/A -73.69% Do insiders & institutionals hold more shares of JATT or ALBT? 48.0% of JATT Acquisition shares are held by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are held by institutional investors. 20.0% of JATT Acquisition shares are held by insiders. Comparatively, 37.3% of Avalon GloboCare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAvalon GloboCare beats JATT Acquisition on 5 of the 9 factors compared between the two stocks. Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALBT vs. The Competition Export to ExcelMetricAvalon GloboCareBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.29M$2.84B$5.36B$8.40BDividend YieldN/A1.92%5.44%4.20%P/E Ratio-0.1930.7925.5819.72Price / Sales4.72444.21404.29118.65Price / CashN/A168.6838.3134.62Price / Book-0.222.996.744.48Net Income-$16.71M-$72.35M$3.23B$248.37M7 Day Performance4.96%1.49%2.20%5.54%1 Month Performance2.42%8.42%9.98%13.64%1 Year Performance-16.86%-28.81%15.18%7.07% Avalon GloboCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALBTAvalon GloboCare1.2054 of 5 stars$3.81-1.6%N/A-24.1%$6.29M$1.33M-0.195Positive NewsJATTJATT AcquisitionN/A$1.47flatN/A-74.1%$25.36MN/A0.003High Trading VolumeTPSTTempest Therapeutics2.6517 of 5 stars$6.85-2.0%$30.00+338.0%-83.7%$25.04MN/A-4.4820Positive NewsCARACara Therapeutics3.4647 of 5 starsN/A$83.52+∞N/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeCASICASI Pharmaceuticals3.8125 of 5 stars$1.92-1.8%$4.00+108.9%-27.4%$23.98M$28.54M-0.86180News CoverageGap UpTENXTenax Therapeutics2.1635 of 5 stars$5.73-0.5%$18.00+214.1%+59.3%$23.77MN/A-1.089CYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870,725.00-0.809PTIXProtagenic Therapeutics0.877 of 5 stars$2.85-9.1%N/A-83.8%$23.49MN/A-2.242Gap DownHigh Trading VolumeKALAKALA BIO3.6324 of 5 stars$3.63-3.2%$15.00+313.2%-49.3%$23.42M$3.89M-0.2930Positive NewsPULMPulmatrix0.7929 of 5 stars$6.41+0.5%N/A+251.7%$23.40M$7.81M-2.4320Analyst ForecastNews CoveragePositive NewsQNTMQuantum BiopharmaN/A$8.59+10.8%N/AN/A$23.25MN/A-0.56N/A Related Companies and Tools Related Companies JATT Acquisition Competitors Tempest Therapeutics Competitors Cara Therapeutics Competitors CASI Pharmaceuticals Competitors Tenax Therapeutics Competitors Cyclo Therapeutics Competitors Protagenic Therapeutics Competitors KALA BIO Competitors Pulmatrix Competitors Quantum Biopharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALBT) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALBT Stock Free ALBT Stock Alerts